| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units, Pediatric | 26 | 2023 | 1024 | 3.020 |
Why?
|
| Heart Defects, Congenital | 69 | 2020 | 4713 | 2.910 |
Why?
|
| Cardiac Surgical Procedures | 52 | 2022 | 3682 | 2.510 |
Why?
|
| Extracorporeal Membrane Oxygenation | 29 | 2017 | 1482 | 2.240 |
Why?
|
| Critical Care | 18 | 2023 | 2717 | 1.920 |
Why?
|
| Cardiopulmonary Bypass | 33 | 2023 | 1097 | 1.620 |
Why?
|
| Coronary Care Units | 5 | 2020 | 235 | 1.430 |
Why?
|
| Fontan Procedure | 15 | 2015 | 805 | 1.430 |
Why?
|
| Hypoplastic Left Heart Syndrome | 20 | 2012 | 595 | 1.420 |
Why?
|
| Oxygen | 16 | 2019 | 4269 | 1.390 |
Why?
|
| Cardiopulmonary Resuscitation | 13 | 2021 | 997 | 1.380 |
Why?
|
| Heart Diseases | 12 | 2019 | 2816 | 1.070 |
Why?
|
| Infant | 93 | 2023 | 36497 | 0.930 |
Why?
|
| Infant, Newborn | 85 | 2022 | 26395 | 0.910 |
Why?
|
| Catheterization, Central Venous | 5 | 2011 | 530 | 0.910 |
Why?
|
| Hypertension, Pulmonary | 6 | 2018 | 1605 | 0.880 |
Why?
|
| Monitoring, Physiologic | 12 | 2019 | 1795 | 0.870 |
Why?
|
| Intraoperative Complications | 4 | 2017 | 1176 | 0.820 |
Why?
|
| Monitoring, Intraoperative | 13 | 2010 | 952 | 0.820 |
Why?
|
| Heart Ventricles | 14 | 2016 | 3839 | 0.800 |
Why?
|
| Child | 98 | 2023 | 80863 | 0.800 |
Why?
|
| Pediatrics | 9 | 2020 | 3622 | 0.800 |
Why?
|
| Cardiac Output | 4 | 2023 | 838 | 0.800 |
Why?
|
| Heart Arrest | 10 | 2019 | 1516 | 0.730 |
Why?
|
| Anesthesia | 9 | 2015 | 1596 | 0.730 |
Why?
|
| Child, Preschool | 75 | 2019 | 42623 | 0.720 |
Why?
|
| Vasodilator Agents | 4 | 2018 | 991 | 0.710 |
Why?
|
| Physiological Phenomena | 1 | 2020 | 18 | 0.700 |
Why?
|
| Respiratory Insufficiency | 4 | 2018 | 1244 | 0.700 |
Why?
|
| Milrinone | 2 | 2023 | 86 | 0.660 |
Why?
|
| Blood Gas Analysis | 2 | 2019 | 384 | 0.650 |
Why?
|
| Vital Signs | 2 | 2018 | 144 | 0.650 |
Why?
|
| Cerebrovascular Circulation | 11 | 2017 | 2737 | 0.640 |
Why?
|
| Respiratory Therapy | 1 | 2019 | 125 | 0.640 |
Why?
|
| Signal Processing, Computer-Assisted | 3 | 2020 | 1496 | 0.630 |
Why?
|
| Blood Coagulation Factors | 4 | 2007 | 366 | 0.630 |
Why?
|
| Critical Illness | 11 | 2022 | 2754 | 0.620 |
Why?
|
| Heart Septal Defects, Atrial | 6 | 2004 | 452 | 0.600 |
Why?
|
| Death | 2 | 2016 | 683 | 0.590 |
Why?
|
| Myocarditis | 5 | 2013 | 804 | 0.570 |
Why?
|
| Phrenic Nerve | 1 | 2017 | 81 | 0.560 |
Why?
|
| Catheter-Related Infections | 2 | 2011 | 275 | 0.560 |
Why?
|
| Hemodilution | 10 | 2014 | 120 | 0.550 |
Why?
|
| Hematocrit | 12 | 2010 | 625 | 0.550 |
Why?
|
| Postoperative Care | 9 | 2014 | 1481 | 0.550 |
Why?
|
| Cross Infection | 4 | 2013 | 1425 | 0.540 |
Why?
|
| Hypothermia, Induced | 17 | 2014 | 756 | 0.540 |
Why?
|
| Cardiology | 2 | 2020 | 1701 | 0.540 |
Why?
|
| Hemodynamics | 21 | 2023 | 4202 | 0.520 |
Why?
|
| Paresis | 1 | 2017 | 177 | 0.520 |
Why?
|
| Cardiac Care Facilities | 1 | 2015 | 35 | 0.510 |
Why?
|
| Pulmonary Artery | 9 | 2010 | 1949 | 0.500 |
Why?
|
| Blood Pressure | 9 | 2023 | 8538 | 0.500 |
Why?
|
| Diaphragm | 1 | 2017 | 360 | 0.500 |
Why?
|
| Hemoglobins | 5 | 2019 | 1532 | 0.480 |
Why?
|
| Information Storage and Retrieval | 1 | 2020 | 823 | 0.470 |
Why?
|
| Intraoperative Period | 2 | 2015 | 513 | 0.460 |
Why?
|
| Fentanyl | 6 | 2005 | 450 | 0.460 |
Why?
|
| Cardiac Output, Low | 2 | 2023 | 191 | 0.450 |
Why?
|
| Postoperative Complications | 23 | 2019 | 15880 | 0.440 |
Why?
|
| Electroencephalography | 11 | 2023 | 6309 | 0.440 |
Why?
|
| Humans | 191 | 2023 | 768451 | 0.440 |
Why?
|
| Perioperative Care | 2 | 2019 | 1046 | 0.430 |
Why?
|
| Vascular Resistance | 2 | 2016 | 941 | 0.420 |
Why?
|
| Norwood Procedures | 5 | 2012 | 192 | 0.420 |
Why?
|
| Professional Role | 1 | 2015 | 316 | 0.410 |
Why?
|
| Cardiovascular Surgical Procedures | 3 | 2010 | 193 | 0.410 |
Why?
|
| Blalock-Taussig Procedure | 4 | 2012 | 60 | 0.390 |
Why?
|
| Heart Rate | 6 | 2019 | 4218 | 0.390 |
Why?
|
| Patient Admission | 2 | 2018 | 1370 | 0.390 |
Why?
|
| Drug Utilization | 1 | 2018 | 1192 | 0.390 |
Why?
|
| Heart | 3 | 2020 | 4451 | 0.390 |
Why?
|
| Bacteremia | 2 | 2009 | 985 | 0.380 |
Why?
|
| Quality Assurance, Health Care | 2 | 2015 | 2179 | 0.380 |
Why?
|
| Off-Label Use | 1 | 2013 | 186 | 0.380 |
Why?
|
| Spectroscopy, Near-Infrared | 11 | 2017 | 752 | 0.370 |
Why?
|
| Heart Arrest, Induced | 10 | 2022 | 361 | 0.370 |
Why?
|
| Cardiotonic Agents | 4 | 2023 | 544 | 0.370 |
Why?
|
| Data Collection | 2 | 2019 | 3329 | 0.370 |
Why?
|
| Nitric Oxide | 2 | 2018 | 2146 | 0.370 |
Why?
|
| Tissue and Organ Procurement | 3 | 2008 | 983 | 0.360 |
Why?
|
| Oximetry | 3 | 2017 | 462 | 0.350 |
Why?
|
| Health Personnel | 2 | 2022 | 3384 | 0.350 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2015 | 470 | 0.350 |
Why?
|
| Respiration, Artificial | 9 | 2018 | 2723 | 0.350 |
Why?
|
| Retrospective Studies | 54 | 2023 | 81834 | 0.340 |
Why?
|
| Anesthesia, General | 6 | 2007 | 1185 | 0.340 |
Why?
|
| Patient Care Team | 5 | 2023 | 2526 | 0.330 |
Why?
|
| Multiple Organ Failure | 2 | 2022 | 387 | 0.320 |
Why?
|
| Quality Improvement | 4 | 2018 | 3858 | 0.310 |
Why?
|
| Anesthetics, Intravenous | 5 | 2005 | 396 | 0.310 |
Why?
|
| Adolescent | 44 | 2023 | 89168 | 0.310 |
Why?
|
| Sternum | 3 | 2000 | 177 | 0.300 |
Why?
|
| Heart Septal Defects, Ventricular | 5 | 2008 | 477 | 0.300 |
Why?
|
| Heart Block | 2 | 2009 | 390 | 0.300 |
Why?
|
| Male | 100 | 2022 | 364781 | 0.290 |
Why?
|
| Education, Distance | 1 | 2011 | 261 | 0.290 |
Why?
|
| Female | 101 | 2019 | 396943 | 0.290 |
Why?
|
| Prospective Studies | 36 | 2022 | 54914 | 0.280 |
Why?
|
| Hyperglycemia | 4 | 2013 | 1389 | 0.280 |
Why?
|
| Blood Transfusion | 2 | 2013 | 1308 | 0.280 |
Why?
|
| Scoliosis | 2 | 2005 | 793 | 0.270 |
Why?
|
| Cause of Death | 3 | 2016 | 3727 | 0.270 |
Why?
|
| Vena Cava, Superior | 2 | 2004 | 197 | 0.270 |
Why?
|
| Fenoldopam | 1 | 2006 | 6 | 0.270 |
Why?
|
| Clinical Competence | 5 | 2020 | 4841 | 0.260 |
Why?
|
| Time Factors | 27 | 2023 | 40271 | 0.260 |
Why?
|
| Leadership | 1 | 2015 | 1395 | 0.260 |
Why?
|
| Intensive Care Units | 6 | 2023 | 3805 | 0.250 |
Why?
|
| Blood Coagulation Disorders | 1 | 2009 | 350 | 0.250 |
Why?
|
| Length of Stay | 13 | 2023 | 6521 | 0.250 |
Why?
|
| Transportation of Patients | 1 | 2006 | 176 | 0.250 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2014 | 1751 | 0.250 |
Why?
|
| Developmental Disabilities | 5 | 2010 | 1516 | 0.240 |
Why?
|
| Medical Errors | 2 | 2017 | 1263 | 0.240 |
Why?
|
| Intensive Care Units, Neonatal | 4 | 2012 | 861 | 0.230 |
Why?
|
| Venae Cavae | 1 | 2004 | 41 | 0.230 |
Why?
|
| Recovery of Function | 2 | 2014 | 2994 | 0.230 |
Why?
|
| Pulmonary Edema | 1 | 2007 | 409 | 0.230 |
Why?
|
| Consensus | 2 | 2011 | 3207 | 0.220 |
Why?
|
| Radial Artery | 1 | 2005 | 188 | 0.220 |
Why?
|
| Hospitals, Pediatric | 9 | 2020 | 1876 | 0.220 |
Why?
|
| Postoperative Period | 12 | 2014 | 1833 | 0.220 |
Why?
|
| Edema | 2 | 2006 | 766 | 0.220 |
Why?
|
| Cardiac Tamponade | 1 | 2004 | 175 | 0.220 |
Why?
|
| Femoral Artery | 2 | 2014 | 829 | 0.210 |
Why?
|
| Anesthesia, Inhalation | 2 | 2002 | 221 | 0.210 |
Why?
|
| Surgical Wound Infection | 3 | 2013 | 1544 | 0.210 |
Why?
|
| Lyme Disease | 1 | 2009 | 631 | 0.210 |
Why?
|
| Heart Injuries | 1 | 2004 | 207 | 0.210 |
Why?
|
| Databases, Factual | 3 | 2018 | 8081 | 0.210 |
Why?
|
| Diuretics | 1 | 2006 | 612 | 0.200 |
Why?
|
| Hypotension | 2 | 2007 | 888 | 0.200 |
Why?
|
| Catheterization, Peripheral | 1 | 2006 | 346 | 0.200 |
Why?
|
| Thrombosis | 2 | 2009 | 2956 | 0.200 |
Why?
|
| Statistics, Nonparametric | 6 | 2007 | 2863 | 0.200 |
Why?
|
| Boston | 11 | 2021 | 9361 | 0.200 |
Why?
|
| Echocardiography, Transesophageal | 4 | 2007 | 1095 | 0.200 |
Why?
|
| Medication Errors | 1 | 2008 | 783 | 0.190 |
Why?
|
| Treatment Outcome | 36 | 2015 | 65409 | 0.190 |
Why?
|
| Safety Management | 1 | 2007 | 764 | 0.190 |
Why?
|
| Blood Pressure Determination | 1 | 2005 | 646 | 0.190 |
Why?
|
| Congresses as Topic | 2 | 2017 | 810 | 0.190 |
Why?
|
| Blood Coagulation | 2 | 2007 | 1162 | 0.190 |
Why?
|
| Ventricular Function, Left | 1 | 2014 | 3941 | 0.190 |
Why?
|
| Risk Factors | 31 | 2023 | 74915 | 0.190 |
Why?
|
| Heart-Assist Devices | 6 | 2013 | 1292 | 0.180 |
Why?
|
| Reflex Sympathetic Dystrophy | 1 | 2001 | 60 | 0.180 |
Why?
|
| Methyl Ethers | 1 | 2002 | 197 | 0.180 |
Why?
|
| Heart Transplantation | 8 | 2013 | 3291 | 0.180 |
Why?
|
| Infection Control | 1 | 2008 | 985 | 0.180 |
Why?
|
| Anesthetics, Inhalation | 2 | 2004 | 575 | 0.180 |
Why?
|
| Carbon Dioxide | 3 | 2014 | 1152 | 0.180 |
Why?
|
| Palliative Care | 7 | 2014 | 3644 | 0.170 |
Why?
|
| Circumcision, Male | 1 | 2001 | 149 | 0.170 |
Why?
|
| Pacemaker, Artificial | 1 | 2005 | 828 | 0.170 |
Why?
|
| Data Compression | 1 | 2020 | 69 | 0.170 |
Why?
|
| Decision Support Systems, Clinical | 2 | 2020 | 1176 | 0.160 |
Why?
|
| Thrombophilia | 1 | 2002 | 306 | 0.160 |
Why?
|
| Sepsis | 1 | 2013 | 2602 | 0.160 |
Why?
|
| Phosphocreatine | 3 | 1998 | 261 | 0.160 |
Why?
|
| Stress, Physiological | 3 | 2001 | 1409 | 0.160 |
Why?
|
| Risk Assessment | 16 | 2019 | 24311 | 0.150 |
Why?
|
| Anastomosis, Surgical | 4 | 2007 | 993 | 0.150 |
Why?
|
| Teaching Rounds | 1 | 2023 | 280 | 0.150 |
Why?
|
| Drug Prescriptions | 1 | 2008 | 1677 | 0.150 |
Why?
|
| Oxygen Consumption | 3 | 2012 | 1882 | 0.150 |
Why?
|
| Brain | 13 | 2017 | 27438 | 0.150 |
Why?
|
| Evidence-Based Practice | 2 | 2013 | 500 | 0.150 |
Why?
|
| Man-Machine Systems | 1 | 2017 | 42 | 0.150 |
Why?
|
| Interview, Psychological | 1 | 2001 | 812 | 0.150 |
Why?
|
| Intubation, Intratracheal | 3 | 2007 | 1359 | 0.150 |
Why?
|
| Age Factors | 6 | 2019 | 18478 | 0.140 |
Why?
|
| Infusions, Intravenous | 5 | 2014 | 2228 | 0.140 |
Why?
|
| Logistic Models | 10 | 2012 | 13324 | 0.140 |
Why?
|
| Glucocorticoids | 1 | 2007 | 2170 | 0.140 |
Why?
|
| Acute Disease | 7 | 2010 | 7246 | 0.140 |
Why?
|
| Propofol | 2 | 2001 | 607 | 0.140 |
Why?
|
| Hemangioma | 1 | 2002 | 727 | 0.140 |
Why?
|
| Systole | 1 | 2019 | 938 | 0.140 |
Why?
|
| Follow-Up Studies | 15 | 2017 | 39430 | 0.140 |
Why?
|
| Blood Flow Velocity | 2 | 2004 | 1377 | 0.140 |
Why?
|
| Attitude to Computers | 1 | 2017 | 196 | 0.140 |
Why?
|
| Ventricular Function | 6 | 2012 | 406 | 0.140 |
Why?
|
| Midazolam | 3 | 2004 | 267 | 0.140 |
Why?
|
| Aircraft | 1 | 2017 | 135 | 0.130 |
Why?
|
| Bacterial Infections | 1 | 2004 | 1397 | 0.130 |
Why?
|
| Hospital Mortality | 11 | 2015 | 5371 | 0.130 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2022 | 645 | 0.130 |
Why?
|
| Psychomotor Disorders | 2 | 2014 | 149 | 0.130 |
Why?
|
| Creatine Kinase | 1 | 1998 | 685 | 0.130 |
Why?
|
| Mental Recall | 1 | 2002 | 1226 | 0.130 |
Why?
|
| Spinal Neoplasms | 1 | 2002 | 715 | 0.130 |
Why?
|
| Pulmonary Circulation | 4 | 2008 | 744 | 0.130 |
Why?
|
| Seizures | 3 | 2014 | 2996 | 0.130 |
Why?
|
| Thoracic Surgery | 1 | 2022 | 727 | 0.120 |
Why?
|
| Extracorporeal Circulation | 1 | 2015 | 181 | 0.120 |
Why?
|
| Heart Failure | 4 | 2018 | 11857 | 0.120 |
Why?
|
| Lactic Acid | 6 | 2012 | 1140 | 0.120 |
Why?
|
| Canada | 2 | 2018 | 2143 | 0.120 |
Why?
|
| Morbidity | 2 | 2017 | 1760 | 0.120 |
Why?
|
| Venous Thrombosis | 1 | 2004 | 1318 | 0.120 |
Why?
|
| Resuscitation | 4 | 2008 | 680 | 0.120 |
Why?
|
| Administration, Inhalation | 1 | 2018 | 1170 | 0.120 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2017 | 308 | 0.120 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2018 | 280 | 0.120 |
Why?
|
| Electrocardiography | 2 | 2023 | 6410 | 0.120 |
Why?
|
| Brain Infarction | 2 | 2014 | 290 | 0.120 |
Why?
|
| Operating Rooms | 2 | 2002 | 799 | 0.110 |
Why?
|
| Pulmonary Atresia | 2 | 2012 | 159 | 0.110 |
Why?
|
| Advisory Committees | 1 | 2018 | 797 | 0.110 |
Why?
|
| Nervous System Diseases | 1 | 2004 | 1668 | 0.110 |
Why?
|
| Faculty, Medical | 1 | 2022 | 1218 | 0.110 |
Why?
|
| Survival Analysis | 11 | 2011 | 10125 | 0.110 |
Why?
|
| Standard of Care | 1 | 2017 | 571 | 0.110 |
Why?
|
| Heart Bypass, Right | 2 | 2010 | 75 | 0.100 |
Why?
|
| Hypnotics and Sedatives | 1 | 2001 | 1188 | 0.100 |
Why?
|
| Blood Glucose | 5 | 2013 | 6429 | 0.100 |
Why?
|
| Adenosine Triphosphate | 2 | 1998 | 2003 | 0.100 |
Why?
|
| Orthopedic Procedures | 1 | 2002 | 1280 | 0.100 |
Why?
|
| Anxiety | 2 | 2010 | 4655 | 0.100 |
Why?
|
| Regional Blood Flow | 2 | 2014 | 1502 | 0.100 |
Why?
|
| Perfusion | 4 | 2021 | 1402 | 0.100 |
Why?
|
| Multivariate Analysis | 7 | 2012 | 12096 | 0.100 |
Why?
|
| Hydrocortisone | 3 | 2011 | 1836 | 0.100 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2015 | 411 | 0.100 |
Why?
|
| Enteral Nutrition | 2 | 2009 | 804 | 0.090 |
Why?
|
| Body Temperature | 4 | 2005 | 781 | 0.090 |
Why?
|
| Gestational Age | 5 | 2012 | 3615 | 0.090 |
Why?
|
| Statistics as Topic | 1 | 2017 | 2362 | 0.090 |
Why?
|
| Liver Transplantation | 1 | 2023 | 2399 | 0.090 |
Why?
|
| Hypoglycemic Agents | 3 | 2013 | 3111 | 0.090 |
Why?
|
| Analysis of Variance | 4 | 2010 | 6242 | 0.090 |
Why?
|
| Basal Metabolism | 1 | 2012 | 163 | 0.090 |
Why?
|
| Anesthesia, Intravenous | 2 | 2005 | 130 | 0.090 |
Why?
|
| Theophylline | 1 | 1991 | 133 | 0.090 |
Why?
|
| Neurosurgical Procedures | 1 | 2002 | 2097 | 0.090 |
Why?
|
| Intracranial Hemorrhages | 2 | 2014 | 815 | 0.090 |
Why?
|
| Emergency Medicine | 1 | 2020 | 1222 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 3 | 2018 | 7451 | 0.090 |
Why?
|
| Chile | 1 | 2011 | 258 | 0.090 |
Why?
|
| Drug Therapy, Combination | 2 | 2014 | 6320 | 0.090 |
Why?
|
| Plasma Substitutes | 2 | 2008 | 58 | 0.090 |
Why?
|
| Continuity of Patient Care | 1 | 2017 | 1076 | 0.090 |
Why?
|
| Plasmapheresis | 1 | 1991 | 207 | 0.090 |
Why?
|
| Evoked Potentials | 1 | 2016 | 1057 | 0.090 |
Why?
|
| Perioperative Period | 1 | 2011 | 252 | 0.080 |
Why?
|
| Carotid Arteries | 1 | 2014 | 943 | 0.080 |
Why?
|
| Infant, Premature, Diseases | 3 | 2011 | 712 | 0.080 |
Why?
|
| Catheterization | 2 | 2014 | 1431 | 0.080 |
Why?
|
| Survival Rate | 7 | 2010 | 12875 | 0.080 |
Why?
|
| Infant, Premature | 5 | 2012 | 2124 | 0.080 |
Why?
|
| Situs Inversus | 1 | 2009 | 63 | 0.080 |
Why?
|
| Hydrogen-Ion Concentration | 6 | 2009 | 2488 | 0.080 |
Why?
|
| Cohort Studies | 10 | 2018 | 41797 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2014 | 10784 | 0.080 |
Why?
|
| Truncus Arteriosus, Persistent | 1 | 2009 | 63 | 0.080 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2009 | 82 | 0.080 |
Why?
|
| Factor VIII | 2 | 2009 | 349 | 0.080 |
Why?
|
| Analgesics, Opioid | 1 | 2005 | 3837 | 0.080 |
Why?
|
| Propensity Score | 2 | 2015 | 1971 | 0.080 |
Why?
|
| Communication | 2 | 2023 | 3910 | 0.080 |
Why?
|
| Cardiology Service, Hospital | 1 | 2010 | 241 | 0.080 |
Why?
|
| Prostheses and Implants | 1 | 1995 | 1279 | 0.080 |
Why?
|
| Infant Mortality | 4 | 2015 | 756 | 0.080 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 3 | 2014 | 281 | 0.070 |
Why?
|
| Patient Simulation | 1 | 2010 | 297 | 0.070 |
Why?
|
| Parents | 1 | 2002 | 3596 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2016 | 36840 | 0.070 |
Why?
|
| Blood Coagulation Tests | 1 | 2009 | 271 | 0.070 |
Why?
|
| Brain Injuries | 2 | 2017 | 2060 | 0.070 |
Why?
|
| Brain Ischemia | 4 | 2004 | 3038 | 0.070 |
Why?
|
| Probability | 3 | 2008 | 2483 | 0.070 |
Why?
|
| Guideline Adherence | 1 | 2018 | 2239 | 0.070 |
Why?
|
| Central Nervous System Diseases | 2 | 2009 | 521 | 0.070 |
Why?
|
| Health Status | 2 | 2019 | 4096 | 0.070 |
Why?
|
| Preoperative Care | 2 | 2009 | 2257 | 0.070 |
Why?
|
| Decision Support Techniques | 1 | 2017 | 2010 | 0.070 |
Why?
|
| Double-Blind Method | 4 | 2014 | 12450 | 0.070 |
Why?
|
| Cooperative Behavior | 1 | 2014 | 1514 | 0.070 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2009 | 262 | 0.070 |
Why?
|
| Pulmonary Gas Exchange | 2 | 2014 | 389 | 0.070 |
Why?
|
| Isoflurane | 2 | 2004 | 384 | 0.070 |
Why?
|
| Brain Diseases | 3 | 2009 | 1553 | 0.070 |
Why?
|
| Biological Transport | 1 | 2011 | 2089 | 0.070 |
Why?
|
| Tetralogy of Fallot | 2 | 2009 | 628 | 0.070 |
Why?
|
| Intention to Treat Analysis | 3 | 2013 | 417 | 0.070 |
Why?
|
| Neuromuscular Blocking Agents | 1 | 2007 | 132 | 0.070 |
Why?
|
| Life Support Care | 1 | 2008 | 226 | 0.070 |
Why?
|
| Evidence-Based Medicine | 2 | 2022 | 3708 | 0.070 |
Why?
|
| Brain Damage, Chronic | 2 | 2015 | 266 | 0.070 |
Why?
|
| Swine | 10 | 2004 | 5996 | 0.070 |
Why?
|
| Heart Function Tests | 1 | 2007 | 318 | 0.070 |
Why?
|
| Prenatal Diagnosis | 2 | 2010 | 1274 | 0.070 |
Why?
|
| Body Weight | 6 | 2006 | 4630 | 0.070 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2006 | 93 | 0.070 |
Why?
|
| Diuresis | 1 | 2006 | 106 | 0.060 |
Why?
|
| Urination | 1 | 2007 | 203 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2009 | 3783 | 0.060 |
Why?
|
| Erythrocyte Transfusion | 1 | 2011 | 574 | 0.060 |
Why?
|
| Infant Nutrition Disorders | 1 | 2006 | 70 | 0.060 |
Why?
|
| Catheters, Indwelling | 1 | 2008 | 436 | 0.060 |
Why?
|
| ABO Blood-Group System | 1 | 2008 | 381 | 0.060 |
Why?
|
| Critical Pathways | 1 | 2009 | 476 | 0.060 |
Why?
|
| Arrhythmias, Cardiac | 4 | 2018 | 2258 | 0.060 |
Why?
|
| Chi-Square Distribution | 2 | 2010 | 3438 | 0.060 |
Why?
|
| Societies, Medical | 3 | 2016 | 3955 | 0.060 |
Why?
|
| Parenteral Nutrition | 2 | 2009 | 663 | 0.060 |
Why?
|
| Magnesium | 2 | 2000 | 816 | 0.060 |
Why?
|
| Education, Medical, Continuing | 1 | 2010 | 829 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2017 | 4049 | 0.060 |
Why?
|
| Attitude of Health Personnel | 2 | 2010 | 3922 | 0.060 |
Why?
|
| Pancuronium | 1 | 2004 | 44 | 0.060 |
Why?
|
| Prone Position | 1 | 2005 | 203 | 0.060 |
Why?
|
| North America | 3 | 2012 | 1292 | 0.060 |
Why?
|
| Constriction | 1 | 2004 | 168 | 0.060 |
Why?
|
| Equipment Design | 2 | 2017 | 3530 | 0.060 |
Why?
|
| Cardioplegic Solutions | 2 | 2022 | 123 | 0.060 |
Why?
|
| Adenosine Deaminase | 1 | 2006 | 253 | 0.060 |
Why?
|
| Triiodothyronine | 1 | 2005 | 492 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 5 | 2012 | 6537 | 0.060 |
Why?
|
| Lung Transplantation | 1 | 2013 | 1310 | 0.060 |
Why?
|
| Registries | 5 | 2015 | 8373 | 0.060 |
Why?
|
| Cell Hypoxia | 1 | 2006 | 661 | 0.050 |
Why?
|
| Disease-Free Survival | 2 | 2012 | 6856 | 0.050 |
Why?
|
| Factor X | 1 | 2003 | 64 | 0.050 |
Why?
|
| Electrophysiology | 2 | 2004 | 1266 | 0.050 |
Why?
|
| Neuromuscular Nondepolarizing Agents | 1 | 2004 | 145 | 0.050 |
Why?
|
| Medical Illustration | 1 | 2004 | 135 | 0.050 |
Why?
|
| Etomidate | 1 | 2005 | 185 | 0.050 |
Why?
|
| Anthropology, Cultural | 1 | 2023 | 103 | 0.050 |
Why?
|
| Fractures, Bone | 1 | 2015 | 2063 | 0.050 |
Why?
|
| Plasminogen | 1 | 2003 | 144 | 0.050 |
Why?
|
| Antithrombin III | 1 | 2003 | 128 | 0.050 |
Why?
|
| Protein C | 1 | 2003 | 134 | 0.050 |
Why?
|
| Factor VII | 1 | 2003 | 139 | 0.050 |
Why?
|
| Prothrombin | 1 | 2003 | 192 | 0.050 |
Why?
|
| Ventricular Function, Right | 1 | 2007 | 629 | 0.050 |
Why?
|
| Factor V | 1 | 2003 | 168 | 0.050 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2009 | 327 | 0.050 |
Why?
|
| Withholding Treatment | 1 | 2007 | 621 | 0.050 |
Why?
|
| Echocardiography | 1 | 2015 | 5043 | 0.050 |
Why?
|
| Equipment Failure | 1 | 2004 | 585 | 0.050 |
Why?
|
| Reoperation | 5 | 2012 | 4342 | 0.050 |
Why?
|
| GABA Modulators | 1 | 2002 | 109 | 0.050 |
Why?
|
| Aneurysm, False | 1 | 2004 | 263 | 0.050 |
Why?
|
| Airway Obstruction | 1 | 2007 | 672 | 0.050 |
Why?
|
| Censuses | 1 | 2023 | 198 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2010 | 22293 | 0.050 |
Why?
|
| Gadolinium | 1 | 2007 | 965 | 0.050 |
Why?
|
| Inflammation Mediators | 1 | 2010 | 1892 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2009 | 5042 | 0.050 |
Why?
|
| Informed Consent | 1 | 2008 | 1012 | 0.050 |
Why?
|
| Clinical Protocols | 2 | 2018 | 1444 | 0.050 |
Why?
|
| Waiting Lists | 2 | 2003 | 778 | 0.050 |
Why?
|
| Energy Metabolism | 1 | 2012 | 2901 | 0.050 |
Why?
|
| Brain Mapping | 1 | 2016 | 6740 | 0.050 |
Why?
|
| Adenoidectomy | 1 | 2002 | 168 | 0.040 |
Why?
|
| Lumbosacral Region | 1 | 2002 | 294 | 0.040 |
Why?
|
| Hormones | 2 | 2001 | 870 | 0.040 |
Why?
|
| Insulin | 2 | 2013 | 6606 | 0.040 |
Why?
|
| Glucose | 2 | 2004 | 4355 | 0.040 |
Why?
|
| Apgar Score | 2 | 2011 | 126 | 0.040 |
Why?
|
| Calibration | 2 | 2017 | 823 | 0.040 |
Why?
|
| Adult | 14 | 2017 | 223542 | 0.040 |
Why?
|
| Pulmonary Veins | 1 | 2006 | 755 | 0.040 |
Why?
|
| Norepinephrine | 2 | 2001 | 900 | 0.040 |
Why?
|
| Intestines | 1 | 2009 | 1912 | 0.040 |
Why?
|
| Magnesium Deficiency | 1 | 2000 | 48 | 0.040 |
Why?
|
| Neural Tube Defects | 1 | 2002 | 255 | 0.040 |
Why?
|
| Prognosis | 4 | 2019 | 30028 | 0.040 |
Why?
|
| Hemophilia A | 1 | 2003 | 359 | 0.040 |
Why?
|
| Dopamine | 1 | 2007 | 1616 | 0.040 |
Why?
|
| Emergencies | 1 | 2006 | 1222 | 0.040 |
Why?
|
| Consciousness | 1 | 2005 | 603 | 0.040 |
Why?
|
| Psychomotor Performance | 1 | 2008 | 1894 | 0.040 |
Why?
|
| Vascular Surgical Procedures | 1 | 2008 | 1509 | 0.040 |
Why?
|
| Pregnancy Outcome | 1 | 2010 | 2959 | 0.040 |
Why?
|
| Epinephrine | 2 | 2001 | 795 | 0.040 |
Why?
|
| Recurrent Laryngeal Nerve | 1 | 2000 | 145 | 0.040 |
Why?
|
| Tonsillectomy | 1 | 2002 | 278 | 0.040 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 2145 | 0.040 |
Why?
|
| Internet | 1 | 2011 | 3123 | 0.040 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2000 | 216 | 0.040 |
Why?
|
| Rewarming | 1 | 1998 | 64 | 0.040 |
Why?
|
| Tachycardia, Supraventricular | 2 | 2005 | 273 | 0.040 |
Why?
|
| Echocardiography, Doppler | 2 | 2012 | 899 | 0.040 |
Why?
|
| Pentylenetetrazole | 1 | 1998 | 72 | 0.040 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2008 | 1460 | 0.040 |
Why?
|
| Hypoxia, Brain | 1 | 1998 | 139 | 0.040 |
Why?
|
| Hospitalization | 1 | 2018 | 10845 | 0.040 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2000 | 297 | 0.040 |
Why?
|
| Animals | 14 | 2016 | 169418 | 0.040 |
Why?
|
| Nutritional Status | 1 | 2006 | 1623 | 0.040 |
Why?
|
| Family | 1 | 2008 | 3208 | 0.030 |
Why?
|
| Oligosaccharides | 1 | 1999 | 406 | 0.030 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2003 | 843 | 0.030 |
Why?
|
| Research Design | 4 | 2020 | 6217 | 0.030 |
Why?
|
| Attitude | 1 | 2002 | 773 | 0.030 |
Why?
|
| Organ Transplantation | 1 | 2007 | 1177 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2023 | 964 | 0.030 |
Why?
|
| Cardiomyopathies | 1 | 2009 | 2056 | 0.030 |
Why?
|
| Phosphorus | 1 | 1998 | 336 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2006 | 3664 | 0.030 |
Why?
|
| Acidosis, Respiratory | 1 | 1996 | 37 | 0.030 |
Why?
|
| Embolization, Therapeutic | 2 | 2004 | 1435 | 0.030 |
Why?
|
| Odds Ratio | 4 | 2012 | 9687 | 0.030 |
Why?
|
| Pregnancy Complications | 1 | 2010 | 2969 | 0.030 |
Why?
|
| Catalysis | 1 | 1998 | 769 | 0.030 |
Why?
|
| Oxyhemoglobins | 3 | 2004 | 213 | 0.030 |
Why?
|
| Terminal Care | 1 | 2008 | 1773 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 15638 | 0.030 |
Why?
|
| Aspartate Aminotransferases | 2 | 2010 | 414 | 0.030 |
Why?
|
| United States | 3 | 2020 | 73121 | 0.030 |
Why?
|
| Schools, Medical | 1 | 2022 | 881 | 0.030 |
Why?
|
| Bandages | 1 | 1997 | 273 | 0.030 |
Why?
|
| Automation | 1 | 2017 | 588 | 0.030 |
Why?
|
| Incidence | 3 | 2008 | 21552 | 0.030 |
Why?
|
| Brain Death | 2 | 2009 | 360 | 0.030 |
Why?
|
| Reference Values | 1 | 2002 | 4941 | 0.030 |
Why?
|
| Partial Pressure | 1 | 2014 | 247 | 0.030 |
Why?
|
| Tranexamic Acid | 1 | 1997 | 174 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2002 | 1348 | 0.030 |
Why?
|
| Comorbidity | 1 | 2009 | 10601 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2009 | 15460 | 0.030 |
Why?
|
| Cardiovascular System | 1 | 2022 | 838 | 0.030 |
Why?
|
| Glasgow Coma Scale | 1 | 2016 | 581 | 0.030 |
Why?
|
| Body Water | 3 | 2001 | 340 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2010 | 8051 | 0.030 |
Why?
|
| Hospital Charges | 1 | 1996 | 351 | 0.030 |
Why?
|
| Linear Models | 2 | 2017 | 5880 | 0.030 |
Why?
|
| Pregnancy | 3 | 2010 | 30179 | 0.030 |
Why?
|
| Self Concept | 1 | 2020 | 1050 | 0.030 |
Why?
|
| Hyperparathyroidism | 1 | 2015 | 339 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2006 | 4425 | 0.030 |
Why?
|
| Calcitriol | 1 | 2015 | 303 | 0.030 |
Why?
|
| Antifibrinolytic Agents | 1 | 1997 | 289 | 0.030 |
Why?
|
| Spinal Cord | 1 | 2002 | 1814 | 0.030 |
Why?
|
| Contrast Media | 1 | 2007 | 5336 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2020 | 1397 | 0.030 |
Why?
|
| Inflammation | 2 | 2010 | 10865 | 0.030 |
Why?
|
| Electron Transport Complex IV | 3 | 1998 | 192 | 0.030 |
Why?
|
| Confidence Intervals | 2 | 2010 | 2932 | 0.030 |
Why?
|
| Adenosine | 1 | 2018 | 816 | 0.030 |
Why?
|
| Coronary Vessels | 1 | 2004 | 3122 | 0.030 |
Why?
|
| Centrifugation | 1 | 2013 | 122 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 1997 | 643 | 0.030 |
Why?
|
| Advanced Cardiac Life Support | 1 | 2013 | 79 | 0.030 |
Why?
|
| Vomiting | 1 | 1996 | 655 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2018 | 937 | 0.030 |
Why?
|
| Treatment Failure | 2 | 2011 | 2656 | 0.030 |
Why?
|
| Reperfusion Injury | 1 | 1999 | 1034 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2023 | 3115 | 0.030 |
Why?
|
| Proportional Hazards Models | 3 | 2012 | 12561 | 0.020 |
Why?
|
| Tidal Volume | 1 | 2014 | 515 | 0.020 |
Why?
|
| Severity of Illness Index | 3 | 2020 | 15965 | 0.020 |
Why?
|
| Calorimetry, Indirect | 1 | 2012 | 176 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2002 | 2339 | 0.020 |
Why?
|
| Creatinine | 2 | 2010 | 1915 | 0.020 |
Why?
|
| Acoustic Stimulation | 1 | 2016 | 1253 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2018 | 1395 | 0.020 |
Why?
|
| Hemoperfusion | 1 | 1991 | 13 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 2007 | 4285 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2022 | 2785 | 0.020 |
Why?
|
| Proxy | 1 | 2012 | 151 | 0.020 |
Why?
|
| Water-Electrolyte Balance | 1 | 2012 | 326 | 0.020 |
Why?
|
| Hemolysis | 1 | 2013 | 419 | 0.020 |
Why?
|
| Hemosiderin | 1 | 2010 | 41 | 0.020 |
Why?
|
| Quality of Life | 1 | 2012 | 13497 | 0.020 |
Why?
|
| Algorithms | 3 | 2022 | 14158 | 0.020 |
Why?
|
| Magnetics | 1 | 2013 | 599 | 0.020 |
Why?
|
| Analgesia, Epidural | 1 | 1993 | 332 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2016 | 2005 | 0.020 |
Why?
|
| Catheter Ablation | 3 | 2005 | 2775 | 0.020 |
Why?
|
| Medical Audit | 1 | 2011 | 454 | 0.020 |
Why?
|
| Decision Making | 1 | 2023 | 3961 | 0.020 |
Why?
|
| Heart Conduction System | 1 | 1995 | 1009 | 0.020 |
Why?
|
| Poisoning | 1 | 1991 | 252 | 0.020 |
Why?
|
| Teratoma | 1 | 1992 | 405 | 0.020 |
Why?
|
| Group Processes | 1 | 2010 | 228 | 0.020 |
Why?
|
| Parathyroid Hormone | 1 | 2015 | 1804 | 0.020 |
Why?
|
| Manikins | 1 | 2010 | 254 | 0.020 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2009 | 164 | 0.020 |
Why?
|
| Survival | 1 | 2008 | 161 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2010 | 10358 | 0.020 |
Why?
|
| Pressure | 2 | 2004 | 1173 | 0.020 |
Why?
|
| Models, Neurological | 1 | 2016 | 1784 | 0.020 |
Why?
|
| Infant, Low Birth Weight | 1 | 1993 | 875 | 0.020 |
Why?
|
| Choline | 1 | 2009 | 518 | 0.020 |
Why?
|
| Technology | 1 | 2010 | 296 | 0.020 |
Why?
|
| Inservice Training | 1 | 2010 | 377 | 0.020 |
Why?
|
| Regression Analysis | 3 | 2008 | 6353 | 0.020 |
Why?
|
| Neostigmine | 1 | 2007 | 68 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2010 | 705 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 2009 | 577 | 0.020 |
Why?
|
| Abdomen | 1 | 1993 | 1136 | 0.020 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2007 | 143 | 0.020 |
Why?
|
| Aorta | 1 | 2014 | 2046 | 0.020 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2010 | 672 | 0.020 |
Why?
|
| Task Performance and Analysis | 1 | 2010 | 771 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2016 | 2705 | 0.020 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2007 | 242 | 0.020 |
Why?
|
| Pulmonary Valve | 1 | 2009 | 413 | 0.020 |
Why?
|
| Tachycardia | 1 | 2007 | 599 | 0.020 |
Why?
|
| Hypoglycemia | 1 | 2012 | 894 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2010 | 1727 | 0.020 |
Why?
|
| Video Recording | 1 | 2010 | 974 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2010 | 1185 | 0.010 |
Why?
|
| Computer Systems | 1 | 2006 | 470 | 0.010 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2004 | 117 | 0.010 |
Why?
|
| Venous Pressure | 1 | 2004 | 55 | 0.010 |
Why?
|
| Aorta, Thoracic | 2 | 2005 | 1107 | 0.010 |
Why?
|
| Interleukin-1beta | 1 | 2010 | 1021 | 0.010 |
Why?
|
| Neurologic Examination | 2 | 1998 | 916 | 0.010 |
Why?
|
| Protons | 1 | 2009 | 1113 | 0.010 |
Why?
|
| Heart Septal Defects | 1 | 2005 | 191 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 2006 | 574 | 0.010 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2004 | 62 | 0.010 |
Why?
|
| Renal Insufficiency | 1 | 2010 | 809 | 0.010 |
Why?
|
| Program Development | 1 | 2010 | 1296 | 0.010 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2009 | 584 | 0.010 |
Why?
|
| Transposition of Great Vessels | 1 | 2008 | 580 | 0.010 |
Why?
|
| Whole Blood Coagulation Time | 1 | 2003 | 30 | 0.010 |
Why?
|
| Blood Urea Nitrogen | 1 | 2003 | 187 | 0.010 |
Why?
|
| Jugular Veins | 1 | 2004 | 211 | 0.010 |
Why?
|
| Victoria | 2 | 1993 | 64 | 0.010 |
Why?
|
| Social Class | 1 | 2012 | 2000 | 0.010 |
Why?
|
| Biopsy | 2 | 2007 | 6816 | 0.010 |
Why?
|
| Neuropsychological Tests | 2 | 2008 | 7134 | 0.010 |
Why?
|
| Syndrome | 1 | 2009 | 3278 | 0.010 |
Why?
|
| Cognition | 1 | 2020 | 7066 | 0.010 |
Why?
|
| Abnormalities, Multiple | 1 | 2009 | 1424 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2010 | 2508 | 0.010 |
Why?
|
| Immunologic Factors | 1 | 2010 | 1600 | 0.010 |
Why?
|
| Aging | 1 | 2000 | 8761 | 0.010 |
Why?
|
| Abscess | 1 | 2004 | 607 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 2002 | 659 | 0.010 |
Why?
|
| Cold Temperature | 1 | 2004 | 786 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2010 | 3234 | 0.010 |
Why?
|
| Alanine Transaminase | 1 | 2003 | 605 | 0.010 |
Why?
|
| Safety | 1 | 2004 | 1159 | 0.010 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2004 | 959 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 9066 | 0.010 |
Why?
|
| Prosthesis-Related Infections | 1 | 2004 | 491 | 0.010 |
Why?
|
| Prosthesis Design | 1 | 2006 | 2126 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 4362 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4586 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2001 | 1379 | 0.010 |
Why?
|
| Tachycardia, Ventricular | 1 | 2007 | 1309 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2010 | 3854 | 0.010 |
Why?
|
| Child Development | 1 | 2010 | 2328 | 0.010 |
Why?
|
| Blood Cell Count | 1 | 1999 | 402 | 0.010 |
Why?
|
| Colloids | 1 | 1998 | 127 | 0.010 |
Why?
|
| Myocardium | 1 | 2010 | 4788 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 2001 | 962 | 0.010 |
Why?
|
| Hemofiltration | 1 | 1998 | 59 | 0.010 |
Why?
|
| Calcium Chloride | 1 | 1997 | 79 | 0.010 |
Why?
|
| Transaminases | 1 | 1998 | 199 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2007 | 2377 | 0.010 |
Why?
|
| Fibrinogen | 1 | 2000 | 892 | 0.010 |
Why?
|
| Prevalence | 1 | 2014 | 15880 | 0.010 |
Why?
|
| Survivors | 1 | 2007 | 2381 | 0.010 |
Why?
|
| Potassium Chloride | 1 | 1997 | 229 | 0.010 |
Why?
|
| Curriculum | 1 | 2010 | 3778 | 0.010 |
Why?
|
| Massachusetts | 1 | 2009 | 8908 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2009 | 4077 | 0.010 |
Why?
|
| Bicarbonates | 1 | 1997 | 292 | 0.010 |
Why?
|
| Sex Factors | 1 | 2010 | 10647 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2006 | 4029 | 0.010 |
Why?
|
| Staphylococcal Infections | 1 | 2004 | 1412 | 0.010 |
Why?
|
| Electromyography | 1 | 2000 | 1399 | 0.010 |
Why?
|
| Models, Animal | 1 | 2002 | 2126 | 0.010 |
Why?
|
| Inpatients | 1 | 2007 | 2561 | 0.010 |
Why?
|
| Solutions | 1 | 1995 | 411 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2006 | 3520 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 1997 | 585 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2006 | 20231 | 0.010 |
Why?
|
| Electric Impedance | 1 | 1999 | 796 | 0.010 |
Why?
|
| Reperfusion | 1 | 1995 | 271 | 0.010 |
Why?
|
| Genomics | 1 | 2010 | 5909 | 0.010 |
Why?
|
| Graft Rejection | 1 | 2007 | 4505 | 0.010 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 1 | 1995 | 148 | 0.010 |
Why?
|
| Phosphates | 1 | 1998 | 767 | 0.010 |
Why?
|
| Stents | 1 | 2006 | 3204 | 0.010 |
Why?
|
| Radiography | 1 | 2004 | 6995 | 0.010 |
Why?
|
| Transducers | 1 | 1994 | 245 | 0.010 |
Why?
|
| Middle Aged | 3 | 2017 | 223418 | 0.010 |
Why?
|
| Sacrococcygeal Region | 1 | 1992 | 53 | 0.010 |
Why?
|
| Organ Preservation | 1 | 1995 | 389 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2006 | 7599 | 0.010 |
Why?
|
| Random Allocation | 1 | 1996 | 2399 | 0.010 |
Why?
|
| Electric Countershock | 1 | 1995 | 534 | 0.010 |
Why?
|
| ROC Curve | 1 | 2000 | 3624 | 0.010 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1993 | 619 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 14728 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2006 | 12813 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 26351 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2003 | 3458 | 0.010 |
Why?
|
| Radiology, Interventional | 1 | 1995 | 477 | 0.010 |
Why?
|
| Conscious Sedation | 1 | 1995 | 535 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2006 | 19041 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2006 | 8635 | 0.010 |
Why?
|
| Bupivacaine | 1 | 1993 | 412 | 0.010 |
Why?
|
| Body Composition | 1 | 1999 | 2455 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2001 | 8559 | 0.010 |
Why?
|
| Patient Selection | 1 | 2001 | 4266 | 0.010 |
Why?
|
| Disease Progression | 1 | 2001 | 13655 | 0.000 |
Why?
|
| Neurons | 1 | 1998 | 9504 | 0.000 |
Why?
|
| Mice | 1 | 2006 | 82045 | 0.000 |
Why?
|
| Aged | 1 | 2007 | 171520 | 0.000 |
Why?
|